Affirma Biotech 

Next generation immunotherapeutic drugs for the treatment of severe infections and cancer

OWNER

Maribel Berges (See Profile)


Sector

Biotech

Stage

In vitro, proof of concept

Country

Espanya


New approach to the functional cure of severe infections such as chronic hepatitis B, reverting immune system exhaustion

Common mechanism of action to other infectious diseases and cancer provides a broad spectrum of potential applications.

Committed management team that has long experience in managing biotech start-ups.

Status

Pending

IP Type

Patent

Time

–

Countries

Australia
Austria
Belgium
Canada
China
Denmark
Finland
France
Germany
Israel
Italy
Japan
Netherlands
Russia
South Korea
Spain
Switzerland
USA
United Kingdom

Coverage

Composition of matter patent, that protects a wide family of chemical products and its uses as therapeutic drugs in cancer and infections caused by viral, fungal or bacterial pathogens.
Priority date March 24th 2023

Know more of this patent

View more

This information is confidential, do not share or copy.

You can visit their website or

Download the Pitch Deck

Under evaluation at least till: 10th of May 2023

If you want to have more information or you want to review the project, you have to login or register

KEEP REVIEWING

©2023 BioExpert Network

About cookies

This website uses cookies to give you the best user experience. If you continue browsing you are giving your consent for the acceptance of those cookies and the acceptance of our cookies policy.

If you continue to browse and use this website you are agreeing to comply with and be bound by the following Terms of Use

ACEPTAR
Aviso de cookies

Log in with your credentials

or    

Forgot your details?

Create Account

Skip to toolbar